| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Fei Gao CEO | SSE Exchange | CNE1000053G6 ISIN |
| CN Country | 1,093 Employees | 1 Jun 2026 Last Dividend | 9 Jun 2023 Last Split | - IPO Date |
Founded in 2009 and headquartered in Hangzhou, China, Hangzhou Alltest Biotech Co., Ltd. is a prominent entity in the biotechnological sector, primarily focusing on the research, development, production, and sale of in vitro diagnostic reagents. The company caters to both the domestic Chinese market and an international clientele, reflecting its broad reach in the healthcare industry. Specializing in rapid diagnostic reagents, Hangzhou Alltest Biotech is dedicated to providing advanced solutions for clinical testing, on-site testing, personal health management, and other specialized fields, thereby contributing significantly to the improvement of global healthcare standards.
COVID-19 Antigen and Antibody Tests: High-accuracy tests designed for the detection of SARS-CoV-2, critical for managing and controlling the COVID-19 pandemic. These tests are essential for both clinical diagnosis and epidemiological surveys.
Veterinary Tests: Comprehensive diagnostic solutions catering to the veterinary field, enabling rapid and accurate disease detection in animals. These tests play a crucial role in ensuring animal health and preventing zoonotic diseases.
Fluorescence Immunoassay Tests and Analyzers: Advanced testing equipment and reagents for the sensitive and specific detection of various biomarkers, using fluorescence immunoassay technology. These products are widely used in the diagnosis of infectious diseases, hormone imbalances, and other health conditions.
Urine Analysis Solutions: In-depth diagnostic tools for analyzing urine samples, providing valuable information on renal function, urinary tract infections, and other metabolic disorders.
Biochemistry Reagents: A wide range of reagents used for biochemical analyses in laboratories, aiding in the diagnosis and monitoring of disease states through the biochemical assessment of bodily fluids.
VTM (Viral Transport Media): Essential for the safe and reliable transport of virus specimens, maintaining the viability of viral particles from collection to analysis.
Blood Glucose Monitoring Systems: User-friendly devices essential for daily blood glucose management, catering to the needs of diabetic patients by facilitating self-monitoring of blood glucose levels.
HB Hemoglobin Test Meters: Compact, portable devices used for measuring hemoglobin levels, crucial for diagnosing anemia and monitoring patients' hemoglobin status.
SARS-COV-2 RT-qPCR Assays: Highly sensitive and specific laboratory tests that detect the genetic material of SARS-CoV-2, offering a gold standard for COVID-19 diagnosis. These assays play a pivotal role in pandemic response efforts.
Virus Specimen Stabilizers: Chemical solutions designed to preserve the integrity of viral RNA or DNA in specimens, ensuring accurate results in subsequent tests.
Viral DNA/RNA Extraction Kits: Specialized kits providing the necessary materials for the efficient and effective extraction of viral genetic material, facilitating the accurate diagnosis of viral infections.